The low-valent U(III) complexes [((t-BuArO)3mes)U] and [((AdArO)3N)U] react with CO2 to form the bridging carbonate complexes [{((t-BuArO)3mes)U}2(mu-kappa2:kappa2-CO3)] and [{((AdArO)3N)U}2(mu-eta1:kappa2-CO3)]. Uranium(IV) bridging oxo complexes have been determined to be the intermediate in these transformations.
No takes yet. Share an insight, caveat, or question.
Lam et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: